The U.S. Food and Drug Administration (FDA) released an official statement on September 13, 2019 alerting patients and healthcare providers of a safety concern regarding the drug, ranitidine. This drug is commonly bought and sold under the brand name, Zantac.
This statement followed test findings demonstrating toxic levels of a carcinogenic (cancerous) ingredient known as NDMA in certain formulations of Zantac tablets, capsules, and oral solutions.
As of January 2020, the FDA has alerted the public of multiple voluntary recalls from several major Zantac drug makers.
In response to these findings, thousands of people across the United States have joined Zantac lawsuits against Zantac drug manufacturers for failing to warn and protect consumers from the drug’s cancer-causing effects.
If you or a loved one has been diagnosed with cancer or suffered wrongful death as a result of taking toxic Zantac products, you may be eligible to join others in demanding compensation from the drug makers responsible.
Are you ready to seek justice for a health problem caused by Zantac? The top-rated drug lawsuit attorneys of Florin|Roebig can help you determine your eligibility and effectively represent your interests in seeking compensation for your damages.
What To Know About The Zantac (Ranitidine) Lawsuits
Many individuals who have taken Zantac, or have loved ones who have taken Zantac, are understandably concerned about the recent statements issued by the FDA on the link between Zantac use and cancer.
If you’re concerned about your health after taking Zantac, or have developed cancer after taking the medication, here is the most important information currently available about Zantac recalls and the Zantac lawsuits.
Why Has Zantac Been Recalled?
The short answer to why many Zantac products have been recalled is the recent discovery of a link between Zantac (ranitidine) products and several types of cancer.
This link was discovered from laboratory results out of the Connecticut-based company, Valisure, that showed toxic levels of the environmental contaminant, NDMA, in certain Zantac (ranitidine) products.
These results found NDMA concentrations in Zantac products ranging 3,000 to 31,000 times higher than the FDA’s recommended daily intake of 96 milligrams.
These excessive levels pose a significant concern because, although NDMA is a chemical that is commonly found in water, various meats, vegetables, and dairy products—it is also classified as a carcinogen.
Studies from the 1980s onward have demonstrated a strong link between consuming excessive amounts of NDMA (i.e. higher than the FDA-recommended daily intake) and various types of cancer. The chemical can also be toxic to the liver and lead to liver damage.
Since July 2019, multiple heart and blood pressure medications—including Zantac—have been recalled after finding toxic levels of carcinogens present in these products. An investigation into the scope of the issue is still underway.
What Conditions Does Zantac Treat?
Zantac (ranitidine) is a histamine-2 (H2) blocker medication that is available over-the-counter (OTC) and by prescription to treat various health conditions. It works in the body primarily by reducing the amount of acid produced in the stomach.
Common uses for Zantac include:
- heartburn relief
- gastroesophageal reflux disease (GERD)
- peptic ulcer disease
- Zollinger-Ellison syndrome
How Many People Have Been Affected?
The scope of the impact is still unclear, although thousands of people have already filed a dangerous drug personal injury claim against the primary manufacturers of Zantac for their failure to disclose the risks of taking their products.
In 2016, more than 15 million prescriptions for ranitidine were written in the United States alone. Across the globe, many countries that distribute ranitidine products, including Canada, have issued mandatory recalls for all ranitidine (Zantac) products. At this time, the U.S. has not joined these countries in issuing mandatory recalls.
Are All Forms Of Zantac Unsafe?
The FDA has stated that not all medications in the U.S. marketed under the name ranitidine are being recalled or are necessarily toxic. Updates on the scope of the “impurities” in Zantac products are still being investigated as of the time of this page’s publication.
If you’ve been taking Zantac over-the-counter (OTC) or as prescribed by a doctor for a health condition, contact your prescribing doctor as soon as possible to discuss your options for continuing to take the drug or switching to a safe alternative.
Which Manufacturers Have Issued Recalls For Their Zantac Products?
There has not yet been any mandatory recall issued by the FDA for Zantac products. However, many drug makers who manufacture Zantac products have issued recalls voluntarily in response to cancer-causing concerns.
As of January 27, 2020, pharma manufacturers that have issued recalls of Zantac (ranitidine) medications include:
- Sandoz Inc. (ranitidine hydrochloride capsules)
- Appco Pharma (ranitidine 150mg and 300mg tablets)
- Amneal Pharmaceuticals (ranitidine 150mg and 300mg, and oral syrup 15mg/mL)
- Precision Dose (ranitidine oral syrup, 10 mg/mL)
- Glenmark Pharmaceuticals (ranitidine 150mg and 300mg tablets)
- GSMS (ranitidine HCl 150mg and 300mg capsules)
- American Health Packaging (ranitidine liquid unit dose cups)
- Lannett Company, Inc (ranitidine oral solution 15mg/mL)
- Dr. Reddy’s, Kroger, Walgreens, and others (ranitidine tablets and capsules)
- Novitium Pharma (ranitidine 150mg and 300mg capsules)
- Sanofi (Zantac 150, Zantac 150 Cool Mint, Zantac 75)
- Perrigo company plc (all pack sizes ranitidine)
- Apotex Corp (ranitidine 75 and 150mg tablets)
For the latest information, all updates on drug recalls can be found on the FDA’s official website.
Who Are The Named Defendants In Zantac (Ranitidine) Lawsuits?
There are several Zantac product drug makers who have been named in recent lawsuits for failing to protect consumers from the drug’s NDMA risk.
Some of the biggest manufacturers named in these suits thus far are pharmaceutical giants Sanofi, Pfizer, and Boehringer Ingelheim—all of whom have reaped enormous profits off their Zantac products.
Plaintiffs in Zantac personal injury lawsuits claim these drug makers marketed and sold drugs contaminated with toxic amounts of NDMA, failing to disclose the associated health risks to the government and broader public.
Did Drug Makers Know About Zantac’s Cancerous Effects?
At this time, it is unclear whether makers of Zantac knew of its cancer-causing effects prior to making, distributing, and selling it. There has been no definitive statement released from Zantac drug makers on whether they were truly aware of the cancer risk prior to findings reported by Valisure and the FDA.
However, multiple peer-reviewed studies have indicated that it’s very likely the drug makers were aware of the risk for high NDMA levels in their products and neglected to disclose this risk to the public.
One peer-reviewed study published in the journal Carcinogenesis in 2016 found that healthy male and female patients who had taken ranitidine products were 400 times more likely to have elevated NDMA levels in their urine compared to patients who had not taken ranitidine.
Valisure, the online pharma company who first detected the toxic NDMA levels in Zantac products, has given a statement confirming that the cancer-causing effects of NDMA (and by extension, Zantac) is “well characterized in the scientific literature”.
Types Of Cancer Linked To Zantac
A compelling amount of research has demonstrated that the active ingredient in Zantac, ranitidine hcl, can metabolize to form the chemical, NDMA, which is recognized by the World Health Organization (WHO), the CDC, and other reputable health agencies as a cancer-causing agent.
The primary types of cancer linked to Zantac use include:
- stomach cancer
- bladder cancer
- liver cancer
- lung cancer
- kidney cancer
- angiosarcoma (cancer of the blood)
Additional health problems that could develop as a result of taking recalled forms of Zantac include liver fibrosis, scarring of the liver, and reduced kidney, lung, and liver function.
Types Of Zantac (Ranitidine) Lawsuits
Although many people who have filed a Zantac lawsuit have done so due to developing cancer after taking the drug, this is not true for everyone.
If you took prescription Zantac (ranitidine) for an extensive amount of time and haven’t been diagnosed with cancer, you may still be eligible to file a Zantac class action lawsuit to recover compensation for the money you spent on the medication. If you took Zantac and experienced health issues other than cancer, you may be able to file a Zantac personal injury claim.
Understanding the difference between the types of lawsuits available to file against Zantac manufacturers can help those who have been harmed by the drug’s dangerous effects seek the compensation they deserve and know which claim makes sense for their individual situation.
Zantac (Ranitidine) Personal Injury Lawsuits
Those who have been harmed directly from taking Zantac are experiencing a form of personal injury, i.e. damage to their liver or development of cancer. Filing a claim against Zantac manufacturers or distributors to seek compensation to account for this damage is known as a personal injury claim.
Negligence In A Zantac Personal Injury Claim
A personal injury claim is a lawsuit filed by an individual against a single party or multiple parties who were negligent. In the case of the harmful effects of Zantac, negligent parties are those who failed to warn their patient or consumer about Zantac’s possible cancer-causing risks and, as a result, risked that person’s safety.
Negligence in a personal injury claim means a party had a reasonable duty to protect others, breached that duty, and that breach caused a person harm.
Zantac personal injury claims can be filed against the drug manufacturers, distributors, pharmacies, physicians and any other parties who marketed, sold, or distributed Zantac to individuals and who were aware of its harmful, cancer-causing risks.
Damages Awarded In A Zantac Personal Injury Lawsuit
Damages which may be awarded in a Zantac personal injury claim may depend on a number of factors, such as the type and severity of cancer caused by Zantac.
Other factors which affect how much compensation may be awarded in a personal injury claim include:
- effects on a person’s immediate and long-term health
- effects of the injury (i.e. cancer) on a person’s quality of life
- if the injury affects people close to the individual
- how the injury affects a person’s finances
- how the injury will affect a person’s life overall: future finances, health, and quality of life
Determining who was aware of the drug’s effects, who may have overlooked such vital information, and who was truly unaware can be difficult to determine in these types of cases. For this reason, hiring a dedicated, hard-working, and experienced personal injury attorney to help file your Zantac lawsuit is crucial to the success of your claim.
Zantac (Ranitidine) Wrongful Death Claims
A wrongful death claim is a type of personal injury claim filed by the family members or loved ones of a person who died against someone who can be held liable for the person’s death.
A widow in New Jersey filed a wrongful death claim in January 2020 against one Zantac manufacturer after her husband died of esophageal cancer in 2018. The man who died had been taking a form of Zantac regularly for 15 years prior to his death.
Wrongful death claims attempt to hold negligent parties responsible for the death of people who engaged in activities they were not aware would be harmful—in this case, taking Zantac—and which led to or contributed to their death.
Since wrongful death claims fall under personal injury law, damages awarded for these lawsuits may be similar to those awarded for other personal injury claims. Zantac wrongful death claims may help individuals who have lost loved ones due to the cancer-causing effects of the drug seek justice.
Zantac (Ranitidine) Class Action Lawsuits
Class action lawsuits are initiated by a single person who brings their case to an attorney capable of representing their interests in the lawsuit.
In contrast with individual lawsuits, class action lawsuits are filed with the purpose of demanding compensation for a group of people who have been unlawfully harmed by a product, service, or action.
It’s important to note that the only compensation recoverable for class action lawsuits includes compensation for the money spent on the drug. Individuals who join class action lawsuits will most likely need to provide proof of receipts for their purchases and will only receive damages for what they spent, in total, on the drug.
The size of class action lawsuits can vary, ranging from just a few people joining together to sue a defendant, to thousands or potentially millions of people. Many recent class action drug lawsuits are closer to the latter, as far as the scope of the issue and the estimated number of people affected.
Individuals who join or opt in to class actions are not necessarily required to take on an active role in the legal proceedings. Only one plaintiff, appointed to serve as the lead plaintiff, is required to play an active role in the class action to serve as the public face and primary decision-maker of the class.
The lead plaintiff in a class action has several responsibilities, including:
- hiring an attorney
- coordinating with the attorney throughout the process
- making settlement decisions on behalf of the class
- fairly representing the class
Once the case has been brought to court by the lead plaintiff and their attorney, the court will decide whether the case meets the criteria for class action certification.
Certifying a class action communicates that the court a) recognizes the legitimacy of the legal claim against the defendant and b) recognizes that there is a significant amount of people that have been unlawfully harmed and suffered identical or similar injuries.
Once a class action is certified, all members of the affected class are required to be notified of the class action. The court may accomplish this by sending out direct mailings to those affected and notifying the broader public via the Internet and media.
Class members of the lawsuit will be notified of all important developments in the case and receive an equal share of compensation from the final settlement in the event of a favorable outcome.
Understanding How To File Zantac Claims: Class Action Lawsuits vs. Multidistrict Lawsuits
Navigating the legal world can be difficult for anyone who has not studied to become an attorney, or ever filed a lawsuit. If you’re filing a Zantac lawsuit, you’ll want to understand which type of claim you’re filing and why.
In the case of Zantac lawsuits, this means understanding the difference between class action lawsuits and multidistrict lawsuits.
Class action lawsuits occur when an entire group of people decide to file together against another party for a harmful prescription drug, medical device, or other product.
Multidistrict lawsuits are similar in form to class action lawsuits but differ in many ways. Multidistrict lawsuits are comprised of many individuals filing singular lawsuits against a party or parties.
The main difference between these two types of suits is that a class action becomes a single lawsuit in which one person or a few select people act as the lead plaintiff and very little to no action is required from the rest of the plaintiffs. Settlements are divided among the plaintiffs, with settlement amounts determined on a number of individual factors.
Multidistrict lawsuits, on the other hand, remain individual lawsuits. When many individuals are suing the same party for similar reasons, these suits may be grouped together in order to not bog down the court.
This means one judge will oversee all the proceedings for these lawsuits, from the pretrial hearings to the settlement determinations, but the lawsuits will remain individuals suits.
Determining which suit you should file largely depends on your purpose. If you only want to recover what you spent on Zantac, for example, then a class action lawsuit may suit your needs.
If you have suffered extensive harm after taking Zantac, such as developing cancer or the loss of a loved one, then a personal injury suit may be necessary to recover enough damages to compensate for your loss.
What To Do If You’ve Taken Zantac
If you believe you’ve taken harmful Zantac (ranitidine) drugs, do not stop taking the drug before speaking with your doctor.
Consider taking the following steps if you’ve been diagnosed with cancer or are concerned about your risk for cancer after taking Zantac products:
Contact Your Prescribing Physician Immediately
If you’ve taken one or more of the recalled OTC or prescription Zantac (ranitidine) products, the FDA recommends that you contact your doctor as soon as possible.
Your doctor can provide you with a recommended course of action that is personalized to meet your needs, based on your current health status and available treatment alternatives.
At this time, the FDA recommends that individuals who are concerned about the cancerous effects of Zantac talk to their doctor about switching to another medication similar to Zantac, or find non-pharmaceutical methods for symptom relief.
Examples of alternative medications that are similar to Zantac but do not contain NDMA include:
- Pepcid (famotidine)
- Tagamet (cimetidine)
- Nexium (esomeprazole)
- Prevacid (omeprazole)
Contact An Experienced Dangerous Drug Personal Injury Claim Attorney
Taking legal action against powerful pharmaceutical companies for gross negligence can be intimidating, but rewarding with the right representation on your side.
If you’ve taken Zantac and have since developed cancer or are worried about your cancer risk, you may be eligible to seek financial compensation for physical, psychological, and economic losses.
If you wish to file a personal injury claim to seek justice for Zantac-related harms, it’s in your best interest to contact an attorney as soon as possible to find out if you qualify.
Benefits Of Filing A Zantac (Ranitidine) Lawsuit
If you or a loved one has been harmed by cancer-causing Zantac products, you may be wondering: what are the advantages of filing a lawsuit against the Zantac drug makers? The advantages of filing a claim can be numerous and will depend on the type of claim you file.
Benefits of filing a personal injury claim for harmful effects caused by Zantac may include:
- seeking compensation for direct harm caused by Zantac (effects on health)
- seeking compensation for indirect harm caused by Zantac (such as pain and suffering, effects to relationships, etc.)
- holding drug makers, distributors, marketers, and prescribing physicians accountable for their actions
- prompting change: filing lawsuits against drug manufacturers can force policy changes which ensure they change the drug to make it safe for all consumers
- ensuring safety of others: prompting changes to the drug makeup helps ensure no one else will be harmed by Zantac’s risky effects
- inspiring changes on a grander scale for laws surrounding drug manufacturing: some cases are instrumental in helping
- prompt change for a certain area of law. This generally happens when many people have been harmed by a singular product,
- entity, etc., such as Zantac.
The main benefit of joining a class action lawsuit, in lieu of a personal lawsuit or in addition to it, is recouping what a person spent on a product which turned out to be harmful or defective.
However, other benefits are also possible when joining a Zantac class action lawsuit, such as:
- no responsibility for lawyer or attorney fees, as these are typically paid out of awarded damages
- a class action suit is more viable for people with limited time and financial resources
- building solidarity among individuals who have been unlawfully harmed by the named defendant(s)
- class action lawsuits are more efficient than filing numerous individual lawsuits
- one judgement and one settlement will be offered across the board
- equal share of compensation among plaintiffs in a successful suit (with the possible exception of the lead plaintiff)
- little action required from plaintiffs, excepting the lead representative
Zantac Lawsuit Attorneys Serving The U.S.
If you have taken an over-the-counter or prescription form of Zantac and experienced damaging effects to your health as a result, you’re not alone and you may be able to sue for compensation.
The award-winning legal team of Florin|Roebig can help. Our seasoned team of personal injury attorneys have extensive experience in expertly handling pharmaceutical lawsuits and possess the skills to build a strong case for a favorable outcome.
We currently have several offices spanning across the U.S. in the states of Florida, Texas, Minnesota, and Colorado.
The top-rated dangerous drug personal injury attorneys of Florin|Roebig include:
- Wil H. Florin, B.C.S.
- Tommy D. Roebig, B.C.S.
- Michael L. Walker, B.C.S.
- Chase P. Florin, B.C.S.
- Shaun M. Cummings
- Luca G. Esposito
- Chad K. Florin, M.B.A., LL.M.
- Nicholas S. Costantino
- Jordan A. Kolinski
- Matthew L. McMullen
- Michael A. Ossi, O.C.
- Lawrence J. Najem, O.C.
- Andrew M. Leone, O.C.
- Nollys R. Solarte, O.C.
- Brian R. Dettman, O.C.
Find A Zantac Lawsuit Attorney Near You
Thousands of people have joined Zantac personal injury, wrongful death, and class action lawsuits in order to seek compensation from the drug manufacturers who failed to detect and disclose the drug’s cancerous effects.
Ready to know if you qualify? By contacting our offices, our attorneys can offer a free case evaluation to determine your eligibility in joining others attempting to hold the drugmakers of Zantac accountable for their actions.
Call the offices of Florin|Roebig today to find out if you or a loved one is eligible to pursue legal action against Zantac pharmaceutical companies for their cancer-causing drugs.